Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
- CASPIAN investigators
- Hospital Universitario 12 de Octubre
- BHI of Omsk Region Clinical Oncology Dispensary
- Cancer and Hematology Centers of Western Michigan
- Asklepios Lung Clinic
- Okayama University
- Odessa National Medical University
- Omsk Regional Cancer Center
- Krankenhaus Nord
- Istanbul University - Cerrahpaşa
- Samsung Changwon Hospital
- Kyiv City Clinical Oncological Centre
- Russian Ministry of Health
- AO Ospedali Riuniti PO Vincenzo Cervello
- Charles University
- Zaporizhia Medical Academy of Post-Gradate Education Ministry of Health of Ukraine
- Tuberculosis and Lung Disease Hospital
- Semmelweis University
- University Hospital St. Marina
- AstraZeneca
- University of California at Los Angeles
Research output: Contribution to journal › Article › peer-review
2024
Link opens in a new tab
Scopus
citations